Bing Han
Peking Union Medical College Hospital · Peking Union Medical College
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Bing Han as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:13 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT06848296 · Phase Ib Clinical Study to Evaluate the Safety and Tolerability of VSA012 Injection in Paroxysmal Nocturnal HemoglobinuriaBisirna Therapeutics Pte. Ltd. · active not recruiting · Paroxysmal Nocturnal Hemoglobinuria (PNH) · principal investigator
- Ph4NCT06525948 · Efficacy and Safety of rhTPO in Combination With Cyclosporine Versus Cyclosporine Alone in the Treatment of TD-NSAAPeking Union Medical College Hospital · unknown · Aplastic Anemia, Transfusion-dependent Anemia · principal investigator
- Ph2NCT06523517 · Efficacy and Safety of Eliglustat in Chinese Pediatric Patients With Gaucher Disease Type 1 and Type 3Peking Union Medical College Hospital · unknown · Gaucher Disease · principal investigator
- Ph4NCT06516484 · Ropustin for Refractory Aplastic Anaemia After Radiotherapy - a Single-centre, Prospective, Open-label, Single-arm StudyPeking Union Medical College Hospital · unknown · Aplastic Anemia · principal investigator
- Ph1/Ph2NCT05539248 · A Study on the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of CAN106 in Subjects With PNHCARE Pharma Shanghai Ltd. · unknown · PNH, Hemolysis · principal investigator
- Ph1/Ph2NCT05447494 · Phase 1/2 Study of CAN103 in Subjects With Gaucher DiseaseCANbridge (Suzhou) Bio-pharma Co., Ltd. · unknown · Gaucher Disease, Type 1, Gaucher Disease, Type 3 · principal investigator
- N/ANCT05125341 · Natural History Study of Adult Patients With Paroxysmal Nocturnal Hemoglobinuria of High-risk Hemolysis in ChinaCARE Pharma Shanghai Ltd. · completed · Paroxysmal Nocturnal Hemoglobinuria, Natural History Study · principal investigator
- Ph2/Ph3NCT05024877 · Hetrombopag for Low/Intermediate-1 Risk MDS With ThrombocytopeniaPeking Union Medical College Hospital · unknown · MDS · study director
- Ph2/Ph3NCT05018936 · Efficacy and Safety of Hetrombopag in Non-severe Aplastic AnemiaPeking Union Medical College Hospital · withdrawn · Aplastic Anemia, Drug Effect · study director
- Ph4NCT04470804 · Sirolimus Treatment for Newly Diagnosed Primary Acquired PRCABing Han · completed · Pure Red Cell Aplasia, Acquired · principal investigator
- Ph2NCT04083014 · Single-dose Anti-CD20 Antibody With Bortezomib for Relapsed Refractory Autoimmune Hemolytic AnemiaPeking Union Medical College Hospital · completed · Autoimmune Hemolytic Anemia, Autoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:13 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 22 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:13 UTC. The ranking covers the 200 most relevant of 310 PubMed records, and a shared surname and initials can bring in a namesake. All 310 on PubMed
- Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.N Engl J Med · 20097,011 citationsRCR 164.6
- 605 citationsRCR 17.5
- 561 citationsRCR 18.1
- 342 citationsRCR 12.0
- Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC.J Thorac Oncol · 2021220 citationsRCR 9.6
- First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion-Positive NSCLC.N Engl J Med · 2023214 citationsRCR 16.0
- Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non-Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01).J Clin Oncol · 2023173 citationsRCR 10.8
- CRISPR-Cas9 In Vivo Gene Editing of KLKB1 for Hereditary Angioedema.N Engl J Med · 2024158 citationsRCR 19.6
- Sleep deprivation is hyperalgesic in patients with gastroesophageal reflux disease.Gastroenterology · 2007149 citationsRCR 4.8
- 148 citationsRCR 9.9